Rapt Therapeutics Inc
(RAPT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 169,735 | 47,478 | 38,946 | 24,027 | 24,918 |
| Marketable Securities | 61,320 | 111,384 | 210,122 | 165,627 | 86,592 |
| TOTAL | $235,236 | $161,782 | $252,694 | $192,973 | $115,598 |
| Non-Current Assets | |||||
| PPE Net | 1,367 | 2,448 | 2,539 | 2,741 | 2,982 |
| Other Non-Current Assets | 3,722 | 9,099 | 10,976 | 2,922 | 389 |
| TOTAL | $5,089 | $11,547 | $13,515 | $5,663 | $3,371 |
| Total Assets | $240,325 | $173,329 | $266,209 | $198,636 | $118,969 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 36,275 | 5,176 | 3,365 | 1,999 | 2,383 |
| Accrued Expenses | 9,597 | 14,103 | 8,656 | 6,326 | 4,935 |
| Other current liabilities | 57 | 109 | 32 | 254 | 328 |
| TOTAL | $48,351 | $21,836 | $14,224 | $9,595 | $11,742 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | 1,016 | 4,096 |
| Other Non-Current Liabilities | 2,070 | 4,458 | 6,819 | 2,150 | 2,185 |
| TOTAL | $2,070 | $4,458 | $6,819 | $2,661 | $3,048 |
| Total Liabilities | $50,421 | $26,294 | $21,043 | $12,256 | $14,790 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 16,501 | 4,350 | 4,286 | 3,697 | 3,108 |
| Common Shares | 13 | 3 | 3 | 3 | 2 |
| Retained earnings | -614,547 | -484,682 | -367,884 | -284,046 | -214,842 |
| Other shareholders' equity | 50 | 103 | -26 | -206 | -177 |
| TOTAL | $189,904 | $147,035 | $245,166 | $186,380 | $104,179 |
| Total Liabilities And Equity | $240,325 | $173,329 | $266,209 | $198,636 | $118,969 |